濮阳东方医院治疗早泄可靠吗(濮阳东方医院看病好又便宜) (今日更新中)

CANBERRA, April 1 (Xinhua) -- People who share bongs to smoke marijuana may be at risk of contracting pulmonary tuberculosis (TB) , Australian medical researchers warned on Friday.Dr Michael Hayes and Dr Susan Miles from Calvary Mater Hospital in Newcastle of Australia conducted the research, which centered on three recent TB cases in New South Wales.TB is caused by the bacteria Mycobacterium tuberculosis, which can be contracted by breathing in air droplets coughed from an infected person.The research suggested a link between active TB cases and shared bongs, which is the water pipes commonly used in marijuana smoking.According to Dr Hayes, the three young patients were regular or heavy cannabis users, and more recently there has been a fourth person in the region with similar characteristics had been diagnosed with TB.He said although the three initial cases were not related, there was concern about the high rate of positive contacts among people who had shared bongs with the active cases."Smoking marijuana is a cough-provoking activity and it is usually conducted in a confined environment that is conducive to the spread of the organism," he told Australia Associated Press.

WASHINGTON, April 6 (Xinhua) -- A study led by researchers at the University of Michigan (U-M) showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects.The study, done in two mouse models of human cancer, looked at two compounds designed to activate a protein that kills cancer cells. The protein, p53, is inactivated in a significant number of human cancers. In some cases, it is because another protein, MDM2, binds to p53 and blocks its tumor suppresser function. This allows the tumor to grow unchecked. The new compounds block MDM2 from binding to p53, consequently activating p53."For the first time, we showed that activation of p53 by our highly potent and optimized MDM2 inhibitors can achieve complete tumor regression in a mouse model of human cancer," says lead study author Shaomeng Wang, director of the Cancer Drug Discovery Program at the U-M Comprehensive Cancer Center.Wang presented the study Wednesday at the American Association for Cancer Research 102nd annual meeting.Many traditional cancer drugs also activate p53 but they do so by causing DNA damage in both tumor cells and normal cells, causing side effects. These new MDM2 inhibitors activate p53 while avoiding the DNA damage common with other drugs. In this study, which was done in collaboration with Ascenta Therapeutics and Sanonfi-Aventis, researchers showed that these new drugs shrank tumors without significant side effects.Because p53 is involved in all types of human cancer, the new drug has potential to be used in multiple types of cancer. Further, the researchers also identified certain markers in tumors that predict which ones will be particularly sensitive to the MDM2 inhibitor, which would allow physicians to target the drug only to patients most likely to benefit.

BEIJING, Feb. 10 (Xinhua) -- The Chinese currency, or the yuan, on Thursday rose to a fresh high of 6.5849 against the U.S. dollar, according to the China Foreign Exchange Trading System.The central parity rate of the yuan, or RMB, was 1 basis point higher than the previous record of 6.585 set on Feb. 9, the previous trading day.The central parity rate has risen against the dollar for a three consecutive trading days.China's central bank announced on June 19 last year that it would further reform the yuan exchange rate formation mechanism to improve its flexibility.On China's foreign exchange spot market, the yuan can rise or fall 0.5 percent from the central parity rate each trading day.The central parity rate of the RMB against the U.S. dollar is based on a weighted average of prices before the opening of the market each business day.

PARIS, May 20 (Xinhua) -- Heavy-load launcher Ariane 5, carrying two communication satellites GSAT-8 and ST-2, lifted off at around 22:38 p.m. Paris time (GMT 2038) on Friday from Europe' s Spaceport in French Guiana.Built by Japan's Mitsubishi Electric Company, ST-2 will offer Ku-and C-band relay services across the Middle East, Central Asia, India and Southeast Asia to the ST-2 Satellite Ventures joint company of Singapore Telecommunications Ltd (SingTel) and Taiwan' s Chunghwa Telecom Company Ltd..With a weight around 5.1 tons at launch, ST-2 was separated first around 27 minutes after the lift-off. It has a designed life of 15 years and will function at 88 degree East.The lighter passenger GSAT-8, built by the Indian Space Research Organization (ISRO), will serve to augment India's Ku- band relay capabilities and offer aircraft navigation assistance over Indian airspace and adjoining areas with its two-channel GAGAN system.GSAT-8 was expected to be ejected off around 31 minutes into the flight and will be orbited at 55 degree East. Weighed about 3. 1 tons, it has a designed life span of at least 12 years.Arianespace started its 2011 busy year for heavy-lift Ariane 5 with the milestone launch of Europe's second Automated Transfer Vehicle (ATV) on February 16.The next launch of Ariane 5 planned to lift off two TV broadcast and telecommunications relay satellites: BSAT-3c/JCSAT- 110R for Japan's Broadcasting Satellite System Corporation (B-SAT) and SKY Perfect JSAT Corporation, and ASTRA 1N for Luxemburg-based SES company.

来源：资阳报